Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 151.87 USD -0.89% Market Closed
Market Cap: 365.6B USD
Have any thoughts about
Johnson & Johnson?
Write Note

Johnson & Johnson
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Johnson & Johnson
Income from Continuing Operations Peer Comparison

Comparables:
BMY
PFE
MRK
ZTS
LLY

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Johnson & Johnson
NYSE:JNJ
Income from Continuing Operations
$14.8B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Income from Continuing Operations
-$7.2B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Income from Continuing Operations
$4.3B
CAGR 3-Years
-40%
CAGR 5-Years
4%
CAGR 10-Years
-9%
Merck & Co Inc
NYSE:MRK
Income from Continuing Operations
$12.2B
CAGR 3-Years
27%
CAGR 5-Years
5%
CAGR 10-Years
8%
Zoetis Inc
NYSE:ZTS
Income from Continuing Operations
$2.4B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
16%
Eli Lilly and Co
NYSE:LLY
Income from Continuing Operations
$8.4B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
12%

See Also

What is Johnson & Johnson's Income from Continuing Operations?
Income from Continuing Operations
14.8B USD

Based on the financial report for Sep 29, 2024, Johnson & Johnson's Income from Continuing Operations amounts to 14.8B USD.

What is Johnson & Johnson's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-2%

Over the last year, the Income from Continuing Operations growth was 19%. The average annual Income from Continuing Operations growth rates for Johnson & Johnson have been -6% over the past three years , 1% over the past five years , and -2% over the past ten years .

Back to Top